Tempest Therapeutics, Inc. — Form 8-K
Filed July 28, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 18/100
What the filing says
On July 27, 2026, Tempest Therapeutics filed an 8-K disclosing Item 5.07 (submission of matters to a vote of security holders) and Item 8.01 (other events). The filing provides no specific dollar amounts, counterparties, transaction terms, share counts, or dates beyond the filing date. The actual content of the matters submitted to vote and the nature of the 'other events' are not detailed in this filing stub.
Why this rating
Filing is procedurally complete but substantively empty—no deal, financing, or operational detail disclosed. Cannot assess materiality without actual event disclosure.
Extracted items
- 5.07 shareholder vote
- 8.01 other event
See more from July 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.